Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,975,689 | 1,710,751 | 991,628 | 2,108,037 | 1,791,517 |
| Marketable Securities | 2,500 | 25,721 | 549,273 | 654,102 | 549,021 |
| Receivables | 38,440 | 36,597 | 34,843 | 35,347 | 65,808 |
| Other current assets | 614,592 | 781,839 | 766,372 | 706,363 | 576,072 |
| TOTAL | $2,631,221 | $2,554,908 | $2,342,116 | $3,503,849 | $2,982,418 |
| Non-Current Assets | |||||
| PPE Net | 13,661,820 | 13,493,110 | 14,287,400 | 13,423,630 | 13,467,210 |
| Investments And Advances | 753,054 | 735,823 | 1,012,477 | 779,523 | 925,389 |
| Other Non-Current Assets | 28,026 | 29,627 | 30,613 | 33,407 | 3,871 |
| TOTAL | $14,442,900 | $14,258,560 | $15,330,490 | $14,236,560 | $14,396,470 |
| Total Assets | $17,074,120 | $16,813,470 | $17,672,610 | $17,740,410 | $17,378,890 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 998,441 | 997,512 | 996,583 | N/A | N/A |
| Accounts payable and accrued liabilities | 105,239 | 102,709 | 121,843 | 128,165 | 122,672 |
| Accrued Expenses | 13,199 | 54,162 | 13,199 | 54,162 | 13,199 |
| Other current liabilities | N/A | 12,400 | N/A | N/A | N/A |
| TOTAL | $1,116,879 | $1,166,783 | $1,131,625 | $182,327 | $135,871 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,122,942 | 6,118,810 | 6,114,677 | 7,106,199 | 7,101,138 |
| Other Non-Current Liabilities | -156,034 | 156,446 | -67,863 | -143,393 | -76,322 |
| TOTAL | $6,135,242 | $6,121,310 | $6,124,577 | $7,149,899 | $7,101,138 |
| Total Liabilities | $7,252,121 | $7,288,093 | $7,256,202 | $7,332,226 | $7,237,009 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 607,138 | 607,224 | 607,222 | 607,220 | 607,178 |
| Common Shares | 108 | 107 | 107 | 107 | 106 |
| Retained earnings | 2,216,811 | 1,964,689 | 2,504,974 | 2,446,132 | 2,224,677 |
| Other shareholders' equity | 3,868,423 | 3,897,417 | 4,281,416 | 4,394,366 | 4,376,893 |
| TOTAL | $9,822,000 | $9,525,373 | $10,416,400 | $10,408,190 | $10,141,880 |
| Total Liabilities And Equity | $17,074,121 | $16,813,466 | $17,672,602 | $17,740,416 | $17,378,889 |